Aveanna Healthcare Holdings Inc (AVAH) PT Lowered to $10 at Jefferies, 'we sell-off as unwarranted'

Jefferies analyst Brian Tanquilt lowered the price target on Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) to $10.00 (from $12.50) while maintaining a Buy rating.

The analyst comments "With AVAH pre-announcing 4Q earnings & FY26 guidance in Jan, we view the print largely as a non-event. Following a strong ’25 driven by execution on its preferred payor strategy & outsized state rate increases, we see ’26 as a normalization yr, w/ PDS returning to MSD % organic growth. That said, healthy FCF generation will support incremental upside via M&A. We see the sell-off as unwarranted & we see this as an attractive buying oppty at ~8.0x '27E EBITDA."

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
• Honeywell International (HON) PT Lowered to $261 at BMO Capital